Stock Analysts Reveal News on Sprint, Dendreon, Yum! Brands, Teva

Sprint Nextel Corp.(NYSE:S): FBR’s channel checks indicate Sprint’s solid execution continues and the firm reiterates an Outperform rating on the stock ahead of the company’s Q4 results on February 8. FBR believes Sprint is on track to exceed consensus expectations in FY12.

Dendreon Corp.(NASDAQ:DNDN): Canaccord said the negative FDA stance on Amgen’s (NASDAQ:AMGN) XGEVA de-risks its outlook for Dendreon’s (NASDAQ:DNDN) Provenge. The firm believes Provenge will occupy a disease treatment setting of newly metastatic disease all alone. Shares are Buy rated.

Yum! Brands, Inc.(NYSE:YUM): After Yum! reported higher than expected Q4 EPS, Bernstein expects the company to benefit from a more benign commodities environment in 2012 and continued strong comps. The firm maintains an Outperform rating.

Teva Pharmaceutical Industries Limited(NASDAQ:TEVA): Bernstein sees several positive catalysts for Teva in the first half of 2012 and the firm maintains an Outperform rating on the stock.

Spirit AeroSystems Holdings Inc(NYSE:SPR): UBS sees further upside to Spirit AeroSystems on higher production rates and cash flow. Shares are Buy rated.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.

To contact the reporter on this story: Derek Hoffman at

To contact the editor responsible for this story: Damien Hoffman at